The identification of all these markers of CV–renal dysfunction as independent risk indicators in the current cohorts of chronic CHD is impressive not least after adjustment for the established and strong biomarkers of renal (Cys-C) and cardiac function (NTproBNP and cTnT-hs) [47]. The gene discussed is NPPB; the disease is coronary artery disorder.